Abstract
Neutralizing antibodies provide rapid immune defense against infectious diseases, but are difficult to discover at scale because neutralization assays require live reporter cells and soluble monoclonal antibodies. Here we report Droplet Reporter Cell Testing for Neutralization (DrReCT-Neutralization) to screen antibody gene libraries for their ability to neutralize viral infections. We established the necessary engineered cell lines and validated the DrReCT screening platform using synthetic oligoclonal libraries, followed by an example discovery campaign that demonstrated scalable functional antibody data collection against viral diseases.
Competing Interest Statement
Massachusetts Institute of Technology, Massachusetts General Hospital, and The University of Kansas have filed for patent protection on the technology described herein, and B.J.D., M.G.G., C.C. A.S.F, N.B., and S.J. are named as co-inventors.